CanadaBis Capital Inc. (CANB.V)
CAD 0.07
(0.0%)
CAD 0.07
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 5.67 Million CAD | 248.6% |
| 2022 | 1.62 Million CAD | 189.86% |
| 2021 | -1.81 Million CAD | 62.12% |
| 2020 | -4.43 Million CAD | -4.41% |
| 2019 | -4.58 Million CAD | -3212.16% |
| 2018 | -138.35 Thousand CAD | 7.89% |
| 2017 | -150.2 Thousand CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 437.64 Thousand CAD | 64.36% |
| 2024 Q1 | 1.09 Million CAD | -34.22% |
| 2024 Q2 | 254.8 Thousand CAD | -74.81% |
| 2023 Q1 | 942.7 Thousand CAD | 30.21% |
| 2023 FY | - CAD | 248.6% |
| 2023 Q2 | 1.58 Million CAD | 67.66% |
| 2023 Q4 | 1.67 Million CAD | 12.59% |
| 2023 Q3 | 1.48 Million CAD | -6.11% |
| 2022 Q4 | 723.97 Thousand CAD | 93.36% |
| 2022 Q3 | 374.4 Thousand CAD | -30.07% |
| 2022 Q2 | 535.43 Thousand CAD | 10671.31% |
| 2022 Q1 | -5065.00 CAD | 99.47% |
| 2022 FY | - CAD | 189.86% |
| 2021 Q4 | -955.61 Thousand CAD | -8531.38% |
| 2021 Q3 | 11.33 Thousand CAD | 103.16% |
| 2021 Q2 | -358.16 Thousand CAD | 43.77% |
| 2021 Q1 | -637 Thousand CAD | -182.06% |
| 2021 FY | - CAD | 62.12% |
| 2020 FY | - CAD | -4.41% |
| 2020 Q1 | -2.76 Million CAD | 30.32% |
| 2020 Q3 | -633.67 Thousand CAD | 45.44% |
| 2020 Q2 | -1.16 Million CAD | 57.98% |
| 2020 Q4 | -225.84 Thousand CAD | 64.36% |
| 2019 Q2 | -75.71 Thousand CAD | -411.96% |
| 2019 FY | - CAD | -3212.16% |
| 2019 Q3 | -433.82 Thousand CAD | -472.98% |
| 2019 Q1 | -14.78 Thousand CAD | -42.05% |
| 2019 Q4 | -3.96 Million CAD | -814.32% |
| 2018 FY | - CAD | 7.89% |
| 2018 Q3 | -30.72 Thousand CAD | 0.0% |
| 2018 Q4 | -10.41 Thousand CAD | 66.12% |
| 2018 Q1 | -5069.00 CAD | 68.91% |
| 2017 Q4 | -16.3 Thousand CAD | 0.0% |
| 2017 FY | - CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Aequus Pharmaceuticals Inc. | -2.68 Million CAD | 311.753% |
| Decibel Cannabis Company Inc. | 5.67 Million CAD | 0.019% |
| Delivra Health Brands Inc. | 2.35 Million CAD | -141.202% |
| Entourage Health Corp. | -21.39 Million CAD | 126.536% |
| Lifeist Wellness Inc. | -12.76 Million CAD | 144.464% |
| Cannara Biotech Inc. | 17.18 Million CAD | 66.964% |
| Medicure Inc. | 1.27 Million CAD | -346.025% |
| PharmaCielo Ltd. | -12.01 Million CAD | 147.243% |
| Rubicon Organics Inc. | 1.94 Million CAD | -191.473% |
| BioSyent Inc. | 9.05 Million CAD | 37.313% |
| Voyageur Pharmaceuticals Ltd. | -1.22 Million CAD | 565.039% |